Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more
Compumedics Ltd (CMP) - Net Assets
Latest net assets as of June 2025: AU$21.82 Million AUD
Based on the latest financial reports, Compumedics Ltd (CMP) has net assets worth AU$21.82 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$54.39 Million) and total liabilities (AU$32.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$21.82 Million |
| % of Total Assets | 40.12% |
| Annual Growth Rate | -1.27% |
| 5-Year Change | -1.5% |
| 10-Year Change | 49.51% |
| Growth Volatility | 23.23 |
Compumedics Ltd - Net Assets Trend (2000–2025)
This chart illustrates how Compumedics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Compumedics Ltd (2000–2025)
The table below shows the annual net assets of Compumedics Ltd from 2000 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$21.82 Million | +19.84% |
| 2024-06-30 | AU$18.21 Million | -0.44% |
| 2023-06-30 | AU$18.29 Million | -22.47% |
| 2022-06-30 | AU$23.59 Million | +6.48% |
| 2021-06-30 | AU$22.16 Million | +1.66% |
| 2020-06-30 | AU$21.79 Million | -20.22% |
| 2019-06-30 | AU$27.32 Million | +17.95% |
| 2018-06-30 | AU$23.16 Million | +15.51% |
| 2017-06-30 | AU$20.05 Million | +37.37% |
| 2016-06-30 | AU$14.60 Million | +29.53% |
| 2015-06-30 | AU$11.27 Million | +22.99% |
| 2014-06-30 | AU$9.16 Million | +9.69% |
| 2013-06-30 | AU$8.35 Million | -9.35% |
| 2012-06-30 | AU$9.21 Million | -27.75% |
| 2011-06-30 | AU$12.76 Million | +4.58% |
| 2010-06-30 | AU$12.20 Million | +6.25% |
| 2009-06-30 | AU$11.48 Million | +34.94% |
| 2008-06-30 | AU$8.51 Million | +23.04% |
| 2007-06-30 | AU$6.91 Million | +2.93% |
| 2006-06-30 | AU$6.72 Million | -28.14% |
| 2005-06-30 | AU$9.35 Million | -32.97% |
| 2004-06-30 | AU$13.95 Million | +19.44% |
| 2003-06-30 | AU$11.68 Million | -61.37% |
| 2002-06-30 | AU$30.23 Million | -6.02% |
| 2001-06-30 | AU$32.16 Million | +6.97% |
| 2000-06-30 | AU$30.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Compumedics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1932.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$39.45 Million | 180.76% |
| Other Comprehensive Income | AU$959.00K | 4.39% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$21.82 Million | 100.00% |
Compumedics Ltd Competitors by Market Cap
The table below lists competitors of Compumedics Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Carrier Connect Data Solutions Inc.
V:CCDS
|
$12.44 Million |
|
Sequoia Financial Group Ltd
AU:SEQ
|
$12.44 Million |
|
Zinitix Co.Ltd
KQ:303030
|
$12.44 Million |
|
ALBIS Leasing AG
XETRA:ALG
|
$12.44 Million |
|
KLA-TENCOR - Dusseldorf Stock Exchang
DU:KLA
|
$12.44 Million |
|
DMS S.A. INH. EO 11845
F:DMS1
|
$12.43 Million |
|
Bakrie & Brothers Tbk
JK:BNBR
|
$12.43 Million |
|
Bor Seker As
IS:BORSK
|
$12.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Compumedics Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,210,000 to 21,823,000, a change of 3,613,000 (19.8%).
- Net loss of 1,272,000 reduced equity.
- Other comprehensive income increased equity by 1,090,999.
- Other factors increased equity by 3,794,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.27 Million | -5.83% |
| Other Comprehensive Income | AU$1.09 Million | +5.0% |
| Other Changes | AU$3.79 Million | +17.39% |
| Total Change | AU$- | 19.84% |
Book Value vs Market Value Analysis
This analysis compares Compumedics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.41x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.35x to 2.41x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-06-30 | AU$0.21 | AU$0.29 | x |
| 2001-06-30 | AU$0.28 | AU$0.29 | x |
| 2002-06-30 | AU$0.22 | AU$0.29 | x |
| 2003-06-30 | AU$0.08 | AU$0.29 | x |
| 2004-06-30 | AU$0.10 | AU$0.29 | x |
| 2005-06-30 | AU$0.07 | AU$0.29 | x |
| 2006-06-30 | AU$0.05 | AU$0.29 | x |
| 2007-06-30 | AU$0.06 | AU$0.29 | x |
| 2008-06-30 | AU$0.06 | AU$0.29 | x |
| 2009-06-30 | AU$0.07 | AU$0.29 | x |
| 2010-06-30 | AU$0.08 | AU$0.29 | x |
| 2011-06-30 | AU$0.08 | AU$0.29 | x |
| 2012-06-30 | AU$0.06 | AU$0.29 | x |
| 2013-06-30 | AU$0.05 | AU$0.29 | x |
| 2014-06-30 | AU$0.05 | AU$0.29 | x |
| 2015-06-30 | AU$0.07 | AU$0.29 | x |
| 2016-06-30 | AU$0.09 | AU$0.29 | x |
| 2017-06-30 | AU$0.11 | AU$0.29 | x |
| 2018-06-30 | AU$0.13 | AU$0.29 | x |
| 2019-06-30 | AU$0.15 | AU$0.29 | x |
| 2020-06-30 | AU$0.12 | AU$0.29 | x |
| 2021-06-30 | AU$0.13 | AU$0.29 | x |
| 2022-06-30 | AU$0.13 | AU$0.29 | x |
| 2023-06-30 | AU$0.10 | AU$0.29 | x |
| 2024-06-30 | AU$0.10 | AU$0.29 | x |
| 2025-06-30 | AU$0.12 | AU$0.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Compumedics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.83%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.49%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 2.49x
- Recent ROE (-5.83%) is above the historical average (-7.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -0.32% | -1.06% | 0.26x | 1.15x | AU$-3.10 Million |
| 2001 | 6.13% | 11.85% | 0.42x | 1.22x | AU$-1.25 Million |
| 2002 | -6.28% | -9.61% | 0.45x | 1.44x | AU$-4.92 Million |
| 2003 | -158.94% | -57.89% | 1.35x | 2.04x | AU$-19.72 Million |
| 2004 | 17.19% | 7.06% | 1.39x | 1.76x | AU$1.00 Million |
| 2005 | -41.70% | -10.12% | 1.57x | 2.63x | AU$-4.83 Million |
| 2006 | -23.75% | -4.10% | 1.75x | 3.30x | AU$-2.27 Million |
| 2007 | 1.78% | 0.33% | 1.92x | 2.78x | AU$-568.40K |
| 2008 | 8.89% | 1.96% | 1.92x | 2.37x | AU$-94.70K |
| 2009 | 23.76% | 7.14% | 1.78x | 1.87x | AU$1.58 Million |
| 2010 | 3.39% | 1.27% | 1.50x | 1.79x | AU$-805.60K |
| 2011 | 0.64% | 0.26% | 1.35x | 1.81x | AU$-1.19 Million |
| 2012 | -30.70% | -10.13% | 1.40x | 2.16x | AU$-3.75 Million |
| 2013 | -17.83% | -5.48% | 1.42x | 2.29x | AU$-2.32 Million |
| 2014 | 9.92% | 3.13% | 1.49x | 2.13x | AU$-7.20K |
| 2015 | 17.48% | 5.88% | 1.55x | 1.92x | AU$843.20K |
| 2016 | 22.42% | 8.72% | 1.44x | 1.79x | AU$1.81 Million |
| 2017 | 6.51% | 3.79% | 1.18x | 1.46x | AU$-700.10K |
| 2018 | 12.02% | 7.52% | 1.07x | 1.50x | AU$468.00K |
| 2019 | 14.70% | 9.68% | 1.07x | 1.42x | AU$1.28 Million |
| 2020 | -26.79% | -16.65% | 0.99x | 1.63x | AU$-8.02 Million |
| 2021 | 4.50% | 2.79% | 0.93x | 1.74x | AU$-1.22 Million |
| 2022 | 5.75% | 3.59% | 0.91x | 1.77x | AU$-1.00 Million |
| 2023 | -33.47% | -14.44% | 1.03x | 2.25x | AU$-7.95 Million |
| 2024 | -1.86% | -0.68% | 1.23x | 2.22x | AU$-2.16 Million |
| 2025 | -5.83% | -2.49% | 0.94x | 2.49x | AU$-3.45 Million |
Industry Comparison
This section compares Compumedics Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $15,365,983
- Average return on equity (ROE) among peers: -346.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Compumedics Ltd (CMP) | AU$21.82 Million | -0.32% | 1.49x | $12.44 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.08 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $91.94 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.72 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.72 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $6.95 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.23 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |